Live Nation shares traded lower Friday as markets digested continuing headlines and uncertainty from the antitrust trial brought by dozens of state attorneys general targeting Live Nation and its ticketing unit, Ticketmaster. The Justice Department’s claims were settled earlier in March, but a large bloc of states has continued pressing the case, keeping investors focused on the range of potential outcomes and remedies.

Even without a new earnings release, legal-process developments can swing sentiment because the case directly challenges business practices that underpin Live Nation’s concert promotion and ticketing ecosystem. With the trial proceeding under the states’ lead, the company faces ongoing headline risk and an extended timeline that can weigh on valuation, particularly after a strong run that leaves less room for uncertainty.

Investors will watch for trial milestones (key witness testimony, court rulings on evidence, and any renewed settlement discussions), plus any signals about what remedies states may seek if they prevail. Traders will also watch whether incremental states join settlements or remain in the case, which could affect perceived litigation exposure and the probability of operational changes.